lapaʻau hou prostate maʻi maʻi maʻi lapaʻau wai radiation Halemaʻi

Lapaʻau ʻana i ka maʻi maʻi maʻi prostate hou i nā halemai hoʻoheheʻe wai pili i nā lāʻau lapaʻau ʻokiʻoki e hāʻawi pololei i ka radiation i nā pūnaewele maʻi maʻi. Hoʻopili kēia ʻatikala i nā kikoʻī o ka radiation wai, ka hoʻohālikelike ʻana me nā ʻano kuʻuna, a me ka hōʻike ʻana i nā haukapila alakaʻi e hāʻawi ana i kēia mau lāʻau lapaʻau hou. E ʻike pehea e hoʻololi ai kēia ʻano hana i ka mālama ʻana i ka maʻi maʻi prostate a me ka hoʻomaikaʻi ʻana i nā hopena no nā poʻe maʻi. ʻO nā lāʻau lapaʻau kuʻuna, ʻo ia ka ʻokiʻoki (prostatectomy), ka lāʻau lapaʻau lāʻau lāʻau waho (EBRT), a me ka lāʻau hormone. ʻO ka hoʻomaʻamaʻa ʻana e hoʻopau holoʻokoʻa i ka prostate gland, ʻoiai e hoʻohana ana ʻo EBRT i nā kukui ikaika kiʻekiʻe e hoʻopaʻa i nā cell cancerous. ʻO ka hormone therapy ka mea e hoʻemi ai i nā pae testosterone, hiki ke hoʻolohi i ka ulu ʻana o ka maʻi kanesa. Eia naʻe, hiki i kēia mau lāʻau lapaʻau ke loaʻa i nā hopena koʻikoʻi, e like me ka incontinence urinary, erectile dysfunction, a me ka luhi. The Rise of Liquid Radiation TherapyʻO ka lāʻau lapaʻau wai, i ʻike ʻia ʻo ka systemic radiation therapy, hāʻawi i kahi ala ʻē aʻe. Ma kahi o nā kukuna waho, hoʻokomo ʻia nā mea radioactive i loko o ke kahe koko, e ʻimi ana i nā maʻi maʻi maʻi a puni ke kino. He mea maikaʻi loa kēia ʻano no ka maʻi maʻi prostate kiʻekiʻe i hoʻolaha ʻia ma waho o ka prostate gland (metastatic prostate cancer). I ka manawa i hoʻopaʻa ʻia ai, kaʻapuni kēia mau radiopharmaceuticals ma ke kahe koko, e ʻimi ana a hoʻopili ʻia i nā sela maʻi prostate. A laila hoʻopuka ka isotope radioactive i ka radiation, hoʻopōʻino a hoʻopau paha i nā keʻena maʻi maʻi. E hōʻoia ana ka mīkini hoʻoholo i ka hāʻawi mua ʻia ʻana o ka radiation i nā cell cancer, e hōʻemi ana i ka pōʻino i nā ʻiʻo olakino. ʻO kēia kahi pōmaikaʻi nui o hoʻoheheʻe wai hoʻohālikelike ʻia me nā ʻano hana hoʻoheheʻe kuʻuna. Nā ʻano o nā lāʻau lapaʻau wai no ka maʻi maʻi prostate hoʻoheheʻe wai loaʻa nā lāʻau lapaʻau no ka mālama ʻana i ka maʻi prostate kiʻekiʻe. Eia kekahi mau hiʻohiʻona koʻikoʻi: ʻO Radium-223 (Xofigo) ʻO Radium-223 kahi isotope radioactive e hoʻohālike ana i ka calcium a kuhikuhi i nā metastases iwi, kahi kahua maʻamau no ka laha ʻana o ka maʻi prostate. Hoʻopuka ʻo ia i nā ʻāpana alpha, he pōkole pōkole a hāʻawi i ka nui o ka radiation i ka iwi, e pepehi ana i nā maʻi maʻi maʻi ʻoiai e mālama ana i nā ʻiʻo a puni. Ua ʻae ʻia ʻo Xofigo no nā poʻe maʻi me ka maʻi maʻi prostate castration-resistant prostate cancer (mCRPC) me nā metastases iwi hōʻailona a ʻaʻohe metastases visceral i ʻike ʻia. Hiki ke loaʻa nā ʻike hou aku e pili ana iā Radium-223 ma ka Paena pūnaewele ʻo American Cancer Society.Lutetium-177 PSMA (Lu-PSMA) TherapyLutetium-177 PSMA he radiopharmaceutical e kuhikuhi ana i ka prostate-specific membrane antigen (PSMA), he protein i loaʻa ma ka ʻili o ka hapa nui o nā maʻi maʻi prostate. Hoʻokuʻu ka isotope lutetium-177 i nā ʻāpana beta, ʻoi aku ka lōʻihi ma mua o nā ʻāpana alpha. ʻAe kēia i ka mālama ʻana i nā maʻi koko ma ke kino holoʻokoʻa. Ua hōʻike ʻo Lu-PSMA therapy i nā hopena maikaʻi loa i nā hoʻokolohua lapaʻau, e hōʻike ana i ka hoʻomaikaʻi ʻana i ka nui o ke ola a me ka maikaʻi o ke ola no nā poʻe maʻi me ka mCRPC i holomua ma luna o nā lāʻau lapaʻau ʻē aʻe.ʻO ka pāhawewe wai hāʻawi i kekahi mau pono kūpono ma mua o nā lāʻau kuʻuna: ʻO ka lāʻau lapaʻau i koho ʻia: Kuhi pololei i nā pūnaeʻa maʻi kanesa, e hōʻemi ana i ka pōʻino i nā ʻiʻo olakino. Lapaʻau ʻōnaehana: Hiki i nā maʻi maʻi maʻi maʻi a puni ke kino, me nā metastases mamao. ʻOi aku ka maikaʻi o ke ola: Hiki ke hopena i nā hopena ʻaoʻao liʻiliʻi ke hoʻohālikelike ʻia me ka radiation kuʻuna a me ka chemotherapy. Pono no ka maʻi maʻi maʻi kiʻekiʻe: Hāʻawi i kahi koho koʻikoʻi no nā poʻe maʻi me ka maʻi maʻi prostate metastatic i hāʻule i nā hana ʻē aʻe. hoʻoheheʻe wai he mea koʻikoʻi no nā hopena maʻi maikaʻi loa. Aia kekahi mau halemai ma ka honua holoʻokoʻa i mua o ka hāʻawi ʻana i kēia mau lāʻau lapaʻau. ʻOiai ʻo nā ʻōlelo aʻoaʻo kikoʻī e koi i kahi kūkākūkā me kahi oncologist kūpono, eia kekahi mau ʻoihana i ʻike ʻia no ko lākou ʻike i ka mālama ʻana i ka maʻi maʻi prostate a hoʻoheheʻe wai: Ke Kulanui o Texas MD Anderson Cancer Center (USA): Kaulana ʻia no ka mālama ʻana i ka maʻi maʻi āpau a me nā hoʻokolohua lapaʻau. Memorial Sloan Kettering Cancer Center (USA): He kikowaena maʻi maʻi alakaʻi me kahi papahana maʻi maʻi prostate i hoʻolaʻa ʻia. Shandong Baofa Cancer Research Institute (Kina): Kūikawā i nā lāʻau lapaʻau maʻi maʻi hou a me ka noiʻi, me hoʻoheheʻe wai. E kipa i kā lākou pūnaewele ma https://baofahospital.com e aʻo hou aʻe e pili ana i kā lākou ala i ka mālama ʻana i ka maʻi maʻi prostate. ʻO Peter MacCallum Cancer Center (Australia): ʻO kahi keʻena noiʻi a me ka mālama ʻana i ka maʻi maʻi honua. ʻO ka mea e manaʻo ai i ka wā o ka lāʻau hoʻoheheʻe ʻana i ka wai hoʻoheheʻe wai ʻO ka mea maʻamau e pili ana i kēia mau ʻanuʻu: Kūkākūkā a loiloi: ʻO kahi loiloi piha ʻana e ka oncologist, me ka nānā ʻana i nā kiʻi a me nā hoʻāʻo koko, e hoʻoholo ai i ka pono no hoʻoheheʻe wai. Hoʻolālā Lapaʻau: Ke hoʻomohala ʻana i kahi hoʻolālā lapaʻau pilikino e pili ana i nā ʻano kikoʻī o ka maʻi kanesa a me ke olakino holoʻokoʻa. Hooponopono: Hāʻawi ʻia ka radiopharmaceutical i loko o ka intravenously, ma ke ʻano he hana maʻi ma waho. Nānā: Ka nānā mau ʻana no ka loiloi ʻana i ka pane lapaʻau a mālama i nā hopena ʻaoʻao. hoʻoheheʻe wai hiki ke ʻae ʻia nā hopena ʻaoʻao. Hiki i nā hopena maʻamau ke komo i ka luhi, nausea, ʻeha iwi, a me nā loli i ka helu koko. ʻO kēia mau hopena ʻaoʻao he maʻalahi a hiki ke mālama ʻia me ka mālama kākoʻo. He mea nui e kūkākūkā i nā hopena ʻaoʻao me kāu oncologist ma mua o ka hoʻomaka ʻana i ka mālama ʻana. The Future of Liquid Radiation in Prostate Cancer TreatmentʻO ka pāhawewe wai he kahua e ulu wikiwiki nei, me ka noiʻi mau ʻana e ʻimi ana i nā radiopharmaceuticals hou a me nā hoʻolālā lapaʻau. Hiki i nā hanana e hiki mai ana ke komo: Novel Radiopharmaceuticals: Ke hoʻomohala nei i nā radiopharmaceuticals hou e hoʻopaʻa i nā molekole like ʻole ma nā maʻi kanesa. Nā lāʻau lapaʻau hui: Hoʻohui hoʻoheheʻe wai me nā lāʻau lapaʻau ʻē aʻe, e like me ka immunotherapy a i ʻole ka chemotherapy. Lapaau pilikino: Hoʻopili i nā hoʻolālā lapaʻau e pili ana i nā ʻano maʻi pākahi a me nā genomic cancer.Making Informed Decisions About Prostate Cancer Treatment ʻO ke koho ʻana i ka lapaʻau kūpono no ka maʻi prostate he hoʻoholo paʻakikī e pono ai ka noʻonoʻo pono ʻana i nā kumu like ʻole, me ke ʻano o ka maʻi kanesa, ke olakino holoʻokoʻa, a me nā makemake pilikino. He mea nui e kūkākūkā i nā koho lapaʻau a pau me kahi oncologist kūpono a e ʻimi i ka manaʻo ʻelua inā pono. ʻO ka hoʻomaopopo ʻana i nā pōmaikaʻi a me nā pilikia o kēlā me kēia ala lapaʻau, me hoʻoheheʻe wai, hiki ke hoʻoikaika i nā poʻe maʻi e hoʻoholo i ka ʻike e pili ana i kā lākou mālama. Inā ʻoe e noʻonoʻo ana i nā koho lapaʻau, e kūkākūkā me ka Shandong Baofa Cancer Research Institute hiki ke hāʻawi i nā ʻike waiwai i nā lāʻau lapaʻau hou e like me ka radiation wai.